Lorenz Lehmann
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac electrophysiology and arrhythmias
- Cardiac Fibrosis and Remodeling
- Cardiomyopathy and Myosin Studies
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 22
- Cardiovascular Function and Risk Factors 9
- Cardiac Fibrosis and Remodeling 7
- Heart Failure Treatment and Management 5
-
- Signaling Pathways in Disease 8
- Histone Deacetylase Inhibitors Research 6
- Co-authors
- Hugo A. Katus (31 shared papers)Johannes Backs (18 shared papers)Michael M. Kreußer (11 shared papers)Markus Heckmann (13 shared papers)Daniel Finke (17 shared papers)Eric N. Olson (3 shared papers)Oliver J. Müller (13 shared papers)David M. Patrick (2 shared papers)
- Journals
- Clinical Research in Cardiology (5 papers)Circulation (5 papers)European Heart Journal (4 papers)Journal of Molecular and Cellular Cardiology (4 papers)PLoS ONE (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Lorenz Lehmann
69 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 101
- Cardiology and Cardiovascular Medicine 898
- Oncology 451
- Molecular Biology 965
- Cancer Research 123
- Aging 13
Countries citing papers authored by Lorenz Lehmann
This map shows the geographic impact of Lorenz Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenz Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenz Lehmann more than expected).
Fields of papers citing papers by Lorenz Lehmann
This network shows the impact of papers produced by Lorenz Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenz Lehmann. The network helps show where Lorenz Lehmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Lorenz Lehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 327 | |
| 2 | 2013 | 159 | |
| 3 | 2014 | 135 | |
| 4 | 2011 | 114 | |
| 5 | 2020 | 103 | |
| 6 | 2021 | 100 | |
| 7 | 2019 | 96 | |
| 8 | 2021 | 76 | |
| 9 | 2014 | 67 | |
| 10 | 2015 | 66 | |
| 11 | 2020 | 65 | |
| 12 | 2019 | 48 | |
| 13 | 2015 | 46 | |
| 14 | 2020 | 44 | |
| 15 | 2013 | 43 | |
| 16 | 2016 | 39 | |
| 17 | 2018 | 34 | |
| 18 | 2016 | 32 | |
| 19 | 2018 | 32 | |
| 20 | 2021 | 31 |
About Lorenz Lehmann
Lorenz Lehmann is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 2.1k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (22 papers), Peptidase Inhibition and Analysis (11 papers), Cardiovascular Function and Risk Factors (9 papers), Signaling Pathways in Disease (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cardiac Fibrosis and Remodeling (7 papers), Histone Deacetylase Inhibitors Research (6 papers) and Heart Failure Treatment and Management (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (898 citations), Oncology (451 citations), Molecular Biology (965 citations), Cancer Research (123 citations) and Aging (13 citations). Lorenz Lehmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hugo A. Katus, Johannes Backs, Michael M. Kreußer, Markus Heckmann, Daniel Finke, Eric N. Olson, Oliver J. Müller, David M. Patrick, Lars S. Maier and Joseph A. Hill. Their work appears in journals such as Clinical Research in Cardiology, Circulation, European Heart Journal, Journal of Molecular and Cellular Cardiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.